Specificity Testing of Antibody and CAR-T Cell Therapies for

In this GEN webinar, our panelists will discuss their experiences using the MPA to rapidly identify potential off-target interactions, resulting in successful IND filings for CAR-T cell therapies where conventional approaches did not suffice.

Related Keywords

Rachel Fong , Donald Siegel , Darshil Patel , Pathology Laboratory Medicine , Division Of Transfusion Medicine Therapeutic Pathology , Preclinical Research , Drug Development Tool , University Of Pennsylvania , Perelman School Of Medicine , Laboratory Medicine Director , Transfusion Medicine , Therapeutic Pathology Director , Advanced Cellular , Integral Molecular , Membrane Proteome Array , Drug Development ,